Legal Issues

Several cease and desist letters were sent to companies in regard to hemp products containing THCA that potentially violate the Missouri Merchandising Practices Act.

Here, we bring you our top five recent articles covering unlicensed cannabis purchases in New Jersey, cannabis found in Haribo candy, regulating cannabis beverages in Kentucky, appeals court rejects argument against federal prohibition, and organic certification in the industry.

According to two House Bills, medical cannabis must now be sold in pre-packaged form, with new regulations and licenses for transportation, storage, and security of facilities.

The law outlines a new framework for the sale of beverages containing intoxicating cannabinoids.

The Court recently published its opinion upholding previous rulings, despite shifting legalization trends in the past two decades.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.

Industry stakeholders responded to the bill, which would prohibit the sale and possession of hemp-derived THC, among other restrictions.

Recently introduced legislation in Maine focuses on testing and safety for medical cannabis in the state.

Here, we bring you our top five recent articles covering a cannabis advertising ban in Mississippi, reforms urged in Canada, the latest Healer webinar, a study on THC and driving skills, and intoxicating hemp product sales in Ohio.

Here, we bring you our top five recent articles covering our newest publication and supplement, the latest Stuck on Compliance blog, data from the National Hemp Report, and cannabis convictions in Maryland.

Maryland Governor Wes Moore recently signed legistlation into law that mandates state officials to automatically shield past and low-level cannabis convictions from public view.

The PREPARE Act would create a new commission that would provide Congress a regulatory framework for cannabis.

Here, we bring you our top five recent news articles covering a Teamsters contract in Maryland, the US Hemp Roundtable and BlueCheck, the launch of Edibles.com, the latest CReDO webinar, and a Texas hemp market report.

Recently, Dr. Ethan Russo traced the history of cannabis prohibition from ancient texts to modern regulations, discussing policy shifts, scheduling, and more.

This month’s Healer webinar explored how recent cannabis policies impact patients, parents, and more.

Here, we bring you our top four recent news articles, covering what's next in the DEA cannabis hearing, cannabis and opioids, the FDA's request for information on cannabis and pets, and Biden's pardons.

Here, we bring you our top five recent news articles, covering delays in the cannabis rescheduling hearings, DoorDash’s expansion into hemp-derived products, and more.

In response to the recent announcement that the hearing concerning cannabis rescheduling had been delayed, Americans for Safe Access held a webinar discussing the impacts medical cannabis.

Cannabis legalization and regulation was noted as an issue with longtime support of a majority of voters in the state.

The recently passed amendment deprioritized cannabis enforcement in Dallas, Texas.

Our sister publication, Nutritional Outlook, covered the current regulatory landscape for hemp as a supplement and how the 2024 Farm Bill could change things in the near future.

The ruling states that federal law does not block the ban on certain cannabinoid products in the state.

A ruling is expected this week regarding the lawsuit challenging the validity of signatures collected for two medical cannabis measures.

Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.

The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.

As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.

The latest webinar in this series explored challenges and solutions in the current and future landscape of cannabis policies and regulation.

Voters in North Dakota will see recreational cannabis on the ballot this November.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

An executive order from the governor pardoned a significant number of cannabis convictions, noting the efforts to rectify harms from past cannabis policies.